New daily pill shows promise for significant weight loss in major trial
NCT ID NCT05890976
Summary
This study tested whether a new daily tablet called semaglutide could help Chinese adults with overweight or obesity lose weight. For about a year, 200 participants took either the real medicine or a placebo pill, while also receiving counseling on healthy eating and physical activity. Researchers measured how much weight people lost and checked for side effects to see if the treatment is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Capital Medical University-Endocrinology
Beijing, Beijing Municipality, 100050, China
-
Changzhou No.2 People's Hospital
Changzhou, Jiangsu, 213003, China
-
Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, 404000, China
-
General Hospital of Tianjin Medical University-Endocrinology
Tianjin, Tianjin Municipality, 300052, China
-
Huaihe Hospital of Henan University-Endocrinology
Kaifeng, Henan, 475000, China
-
Huashan Hospital Fudan University-Endocrinology
Shanghai, Shanghai Municipality, 200040, China
-
Huizhou Central People's Hospital-Endocrinology
Huizhou, Guangdong, 516001, China
-
Jinan Central Hospital
Ji'nan, Shandong, 250013, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Peking University People's Hospital-Endocrinology
Beijing, Beijing Municipality, 100044, China
-
Shanghai Pudong New Area People's Hospital-Endocrinology
Shanghai, Shanghai Municipality, 201200, China
-
Taihe Hospital-Endocrinology
Shiyan, Hubei, 442008, China
-
The Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, 212001, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, 450062, China
-
The First People's Hospital of Changde City-Endocrinology
Changde, Hunan, 415003, China
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011, China
Conditions
Explore the condition pages connected to this study.